The antibiotic resistance of 59 ESBL/AmpC producing E. coli isolates was evaluated by minimum inhibitory concentration (MIC) of cefotaxime and antimicrobial susceptibility test (AST). MIC testing was performed using a micro-broth dilution method that followed the Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI, 2015, 2016). The concentration of cefotaxime was serially diluted with Mueller Hinton Broth (MHB) from 0 to 256 μg/mL with the MIC defined by the highest concentration among three replicates. The ESBL-producing strain KCJ1409 was used as a positive control, and DH5α as a negative control (Mir et al., 2016). The standard Kirby Bauer disk diffusion method on Mueller Hinton Agar (MHA) was used to test susceptibility against the following 13 antibiotics: amikacin (30 μg), ampicillin (10 μg), amoxicillin/clavulanic acid (30 μg), sulfisoxazole (250 μg), ceftiofur (30 μg), chloramphenicol (30 μg), cephalothin (30 μg), gentamicin (10 μg), nalidixic acid (30 μg), streptomycin (10 μg), sulfamethoxazole/trimethoprim (23.75 μg/1.25 μg), tetracycline (30 μg), and colistin (10 μg) (BD, United States). E. coli (ATCC 35401), Staphylococcus aureus (ATCC 25923), and Pseudomonas aeruginosa (ATCC 27853) were used as controls.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.